Immune responses that are associated with a decreased risk of infection are called correlates of protection (CoP). Clinical trials that measure vaccine-induced antibody and cell-mediated immune responses help to define CoP ...
Nov 1, 2019
0
2
A collaboration led by scientists at Tokyo University of Agriculture and Technology (TUAT), Japan, has discovered a novel amyloid protein that induces amyloidosis in rats. This new amyloid protein is known to be the lipopolysaccharide ...
Oct 25, 2019
0
5
When US scientist William Kaelin's phone began ringing at 5:00 am, he wasn't sure whether he was dreaming: Winning the Nobel Medicine Prize had long been a goal, but he also thought it was a long shot.
Oct 8, 2019
0
3
After mass shootings in Ohio and Texas this summer, gun control burst back on the scene as a major political issue for Democrats. Now it risks taking a back seat as impeachment fever overtakes Washington.
Oct 2, 2019
0
1
According to the National Cancer Institute, approximately 38 percent of men and women will be diagnosed with cancer at some point in their lives. The current process for drug discovery is slow and sequential, and often involves ...
Oct 1, 2019
0
2
A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings, published ...
Sep 25, 2019
0
144
(HealthDay)—A frailty assessment as part of liver transplant evaluation may help identify transplant candidates at higher risk for death, according to a study published online Sept. 11 in JAMA Surgery.
Sep 19, 2019
0
9
A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year.
Sep 4, 2019
0
154
In a new study, scientists led by the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research identified a transcriptional signature in B cells associated with protection from SIV or HIV infection ...
Aug 28, 2019
0
84
A Middle East respiratory syndrome coronavirus (MERS CoV) vaccine candidate was shown to be safe, well-tolerated, and induced a robust immune response in a Phase 1 first-in-human clinical trial. Initial findings from the ...
Jul 25, 2019
0
3
